EL7.AI
StocksMedium•17 November 2026•
3 min read

TPG Sells 37,233,110 LifeStance Shares, Retains 11.2% Stake

Key Facts

1TPG sold 37,233,110 shares on November 12, 2026, at $13.02 per share.
2The secondary offering included 45,000,000 shares, of which 37,233,110 were sold by TPG and 7,766,890 by Summit Partners.
3Selling shareholders’ proceeds before expenses totaled $585,900,000, after a deduction of $4,500,000 for commissions and discounts.
4After the offering and planned repurchase, TPG owned about 11.2% and Summit owned about 2.3%.

TPG VIII Lynnwood Holdings Aggregation, L.P. disclosed that it sold 37,233,110 shares of LifeStance Health on November 12, 2026, at $13.02 per share, according to a Form 4 the company filed on November 16. The disclosures show that the transaction was part of a secondary offering conducted by existing shareholders. The offering prospectus supplement set the total number of shares offered at 45,000,000. The sellers included TPG, as well as Summit Partners and its affiliates. Summit accounted for 7,766,890 of the offered shares.

LifeStance priced the offering at $13.12 per share, while the net amount due to sellers was $13.02 per share after underwriting commissions and discounts of $0.10 per share. The selling shareholders’ proceeds before expenses totaled $585,900,000. The prospectus deducted $4,500,000 for underwriting commissions and discounts. The announced offering price differs from the net price in TPG’s disclosure of its sale, with the latter matching the amount due to sellers per share. The proceeds went to the shareholders who sold shares in the secondary offering.

Alongside the shareholders’ sale, LifeStance agreed to repurchase 2,000,000 shares from the underwriters at the same price they paid the sellers. The prospectus estimated the total value of the repurchase at approximately $26,040,000. The company said it would fund the repurchase with available cash. After the offering and planned repurchase, TPG disclosed beneficial ownership of 42,458,592 shares, equal to 11.2% of the common stock. Summit Partners and its affiliates owned 8,856,934 shares, or 2.3%.

The transaction comes as LifeStance reported its third-quarter 2026 results, with revenue rising to $455.9 million from $363.8 million in the same period a year earlier, an increase of 25%. The company said its base of clinicians and practitioners grew 11% to 8,863, while visits rose 17% to 2.7 million. Net income was $22.4 million, compared with $1.1 million in the third quarter of 2025. As of September 30, 2026, cash and cash equivalents totaled $218.8 million, while long-term net debt reached $255.5 million. LifeStance provides virtual and in-person outpatient mental health care for children, adolescents and adults, and operates in 35 states through more than 575 centers.

LifeStance raised its 2026 revenue outlook to a range of $1.741 billion to $1.761 billion and set its adjusted EBITDA outlook at $242 million to $250 million. For the fourth quarter of 2026, the company expects revenue of $446 million to $466 million. It estimated adjusted EBITDA for the same quarter at $56 million to $64 million. These projections place expected financial performance for the next period within ranges the company announced after its third-quarter results. They cover revenue and adjusted operating profitability that LifeStance disclosed for the year and quarter ahead.

Open on chart